q&more
My watch list
my.chemie.de  
Login  

Author

Dr. Gregor Fuhrmann

Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), Nachwuchsgruppe Biogene Nanotherapeutika (BION)

Eilien Schulz/BION

Dr. Gregor Fuhrmann

Gregor Fuhrmann, born in 1982, studied pharmacy at the Free University of Berlin and in 2013 received a doctorate in pharmaceutical sciences from the Swiss Federal Institute of Technology (ETH) Zurich. He spent a postdoctoral period at the Imperial College London and, since 2016, has been head of the Junior Research Group Biogenic Nanotherapeutics (BION) at the Helmholtz Institute for Pharmaceutical Research Saarland.
 

Leitmotif

“The biggest mistake you can make in life is constantly being afraid of making a mistake.”
(Dietrich Bonhoeffer)
 

Activities

Gregor Fuhrmann is co-founder of the German Society for Extracellular Vesicles (GSEV) and has been a member of its board since 2017. He is responsible mainly for public relations and the internet presence and is co-organizer of the 1st GSEV Autumn Meeting. He is also a member of the German Pharmaceutical Society (DPhG) and has already featured as a guest editor for its membership magazine Pharmakon (issue 02/2018, celiac disease). For the DPhG annual meeting 2018, he organized and conducted a session on biogenic and biomimetic drug delivery systems.

Awards

For his PhD thesis, Gregor Fuhrmann received both the ETH Medal and the Rottendorf Europapreis in 2013. In 2017, he was awarded the Technology Prize of the Galenus Foundation, one of the most prestigious young talent awards in pharmaceutical technology. He was a Postdoctoral Fellow of the German Academic Exchange Service in 2013 and a Marie-Curie Intra-European Fellow in 2014/15.

Focus

His research is centered on developing advanced drug carriers to treat infectious diseases, with a focus on biogenic, natural systems, and in particular the role of extracellular vesicles in bacterial infections. Another research interest is developing new therapeutic systems for treating autoimmune diseases of the digestive tract, such as celiac disease or inflammatory bowel disease.

Methods

  • Nanoparticle tracking analysis and dynamic light scattering
  • Electron microscopy and confocal microscopy
  • Asymmetric flow field flow fractionation
  • Preparative size exclusion chromatography
  • Analysis of colony-forming units

Facts, background information, dossiers

  • inflammatory bowel disease
  • celiac disease
  • autoimmune diseases
  • bacterial infections
  • nanotherapeutics
  • pharmacy
  • extracellular vesicles
  • biomimetic drug del…

Other articles by this author

All articles

More about Helmholtz-Institut für Pharmazeutische Forschung

  • News

    How bacteria turn off an antibiotic

    Many common antibiotics are increasingly losing their effectiveness against multi-resistant pathogens, which are becoming ever more prevalent. Bacteria use natural means to acquire mechanisms that protect them from harmful substances. For instance against the agent albicidin: Harmful Gram-n ... more

    Hospital germs have their flaws too

    The hospital germ Pseudomonas aeruginosa can cause serious wound as well as lung and urinary tract infections, especially in weakened individuals. Pseudomonas manages time and again to survive attacks of the immune system and antibiotic therapies. One key to the success of this persistent p ... more

  • q&more articles

    Extracellular vesicles as biogenic transporters of antibiotics

    Developing new antimicrobial treatment strategies is becoming a key challenge in today's medical research. The targeted delivery of drugs into infected human tissue could significantly improve the antibiotic therapies to combat difficult-to-treat microorganisms. more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:

 

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE